Chemical activators of MORN3 function by modulating the cellular levels of cyclic AMP (cAMP), a critical second messenger in various signaling pathways. Forskolin directly stimulates adenylate cyclase, the enzyme responsible for converting ATP to cAMP. This elevation in cAMP immediately leads to the activation of protein kinase A (PKA), a primary effector that phosphorylates target proteins, including MORN3. Isoproterenol, a synthetic compound, acts on beta-adrenergic receptors to similarly increase adenylate cyclase activity and cAMP levels, thereby enabling PKA to activate MORN3. Meanwhile, IBMX raises intracellular cAMP by inhibiting phosphodiesterases, a group of enzymes that degrade cAMP, ensuring that PKA remains active and capable of acting on MORN3. Prostaglandin E2 (PGE2) and histamine exert their effects through G protein-coupled receptors, specifically activating adenylate cyclase, once again increasing cAMP and facilitating the phosphorylation and activation of MORN3 by PKA.
In parallel, dopamine operates through D1-like receptors, also leading to adenylate cyclase activation, raising cAMP, and subsequently activating PKA, which then targets MORN3. Epinephrine works in a similar fashion, binding to beta-adrenergic receptors and catalyzing a cascade that culminates in the activation of MORN3 by PKA. Cholera toxin, however, has a more enduring effect, permanently activating the Gs alpha protein, which leads to a relentless stimulation of adenylate cyclase and an enduring rise in cAMP, keeping PKA perpetually active for MORN3 phosphorylation. Glucagon, which also stimulates adenylate cyclase via its receptor, contributes to the pool of cAMP that activates PKA for MORN3 activation. Rolipram and anagrelide contribute to the elevation of cAMP levels by specifically inhibiting phosphodiesterase 4 and 3, respectively. Their actions prevent the breakdown of cAMP, ensuring sustained activation of PKA, which in turn phosphorylates MORN3. Lastly, terbutaline, a beta2-adrenergic agonist, activates adenylate cyclase, which results in the production of cAMP and the activation of PKA, leading to the phosphorylation and activation of MORN3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP levels by stimulating adenylate cyclase activity. The elevation in cAMP activates PKA, which can phosphorylate and activate MORN3. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, enzymes that degrade cAMP. By preventing cAMP breakdown, IBMX can indirectly increase PKA activity, which may lead to the phosphorylation and activation of MORN3. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) activates G protein-coupled receptors that stimulate adenylate cyclase, increasing cAMP and activating PKA. PKA, in turn, has the potential to phosphorylate and activate MORN3. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can activate H2 receptors, leading to an increase in cAMP levels via adenylate cyclase activation. This rise in cAMP activates PKA, which could phosphorylate and activate MORN3. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to D1-like receptors, which activate adenylate cyclase. The subsequent increase in cAMP activates PKA, which may lead to the phosphorylation and activation of MORN3. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with beta-adrenergic receptors, causing an increase in cAMP levels through stimulation of adenylate cyclase. Elevated cAMP activates PKA, which could activate MORN3 by phosphorylation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, which specifically degrades cAMP. By preventing cAMP degradation, rolipram indirectly increases PKA activity, which could lead to phosphorylation and activation of MORN3. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide inhibits phosphodiesterase 3, leading to an increase in cAMP levels and subsequent activation of PKA. PKA may then phosphorylate and activate MORN3. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline, a beta2-adrenergic agonist, increases intracellular cAMP by stimulating adenylate cyclase. The increased cAMP activates PKA, which is known to phosphorylate and activate MORN3. | ||||||